"
Sensorineural Hearing Loss in Multidrug-Resistant Tuberculosis Patients in Kinshasa (Democratic Republic of Congo): Prospective Cohort Study of Therapeutic Regimen with Aminoglycoside versus Bedaquiline"
written by Mireille A. Mpwate, Eddy M. Mbambu, Christian N. Matanda, Gabriel M. Lema, Michel K. Kaswa, Murielle L. Aloni, Nicole M. Anshambi, Fabrice M. Matuta, Luc L. Lukasu, Dominique M. Mupepe, Serge K. Mpwate, Pierre Z. Akilimali, Zacharie M. Kashongwe, Richard N. Matanda,
published by
Journal of Tuberculosis Research,
Vol.11 No.3, 2023
has been cited by the following article(s):
|
[1]
|
Hearing Impairment Among Drug-Resistant Tuberculosis Patients in Rural Eastern Cape: A Retrospective Analysis of Audiometric Findings
International Journal of Environmental Research and Public Health,
2025
DOI:10.3390/ijerph22050810
|
|
|
|
|
[2]
|
Overview on adverse effects of bedaquiline containing regimens for drug resistant tuberculosis
Discover Medicine,
2025
DOI:10.1007/s44337-025-00493-5
|
|
|
|
|
[3]
|
Determinants of the Sensorineural Hearing Loss in Patients with Multidrug-Resistant Tuberculosis in Kinshasa (Democratic Republic of the Congo): A Prospective Cohort Study
International Journal of Otolaryngology and Head & Neck Surgery,
2023
DOI:10.4236/ijohns.2023.126045
|
|
|
|